Dashenlin Pharm Grp Co Ltd (603233) - Total Liabilities

Latest as of March 2026: CN¥17.65 Billion CNY ≈ $2.58 Billion USD

Based on the latest financial reports, Dashenlin Pharm Grp Co Ltd (603233) has total liabilities worth CN¥17.65 Billion CNY (≈ $2.58 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 603233 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Dashenlin Pharm Grp Co Ltd - Total Liabilities Trend (2012–2025)

This chart illustrates how Dashenlin Pharm Grp Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 603233 current and non-current assets.

Dashenlin Pharm Grp Co Ltd Competitors by Total Liabilities

The table below lists competitors of Dashenlin Pharm Grp Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Solvay SA BR:SOLB	Belgium	€5.06 Billion
Green Brick Partners Inc NYSE:GRBK	USA	$601.78 Million
SKC Co. Ltd KO:011790	Korea	₩5.02 Trillion
Kemira Oyj HE:KEMIRA	Finland	€1.44 Billion
Sportradar Group AG NASDAQ:SRAD	USA	$1.78 Billion
Fortior Technology (Shenzhen) Co. Ltd. A SHG:688279	China	CN¥121.62 Million
Jumbo S.A. AT:BELA	Greece	€272.34 Million
Provident Financial Services Inc NYSE:PFS	USA	$22.76 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Dashenlin Pharm Grp Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Dashenlin Pharm Grp Co Ltd balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.24	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.66	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Dashenlin Pharm Grp Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Dashenlin Pharm Grp Co Ltd (2012–2025)

The table below shows the annual total liabilities of Dashenlin Pharm Grp Co Ltd from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥17.83 Billion ≈ $2.61 Billion	-2.60%
2024-12-31	CN¥18.30 Billion ≈ $2.68 Billion	+13.04%
2023-12-31	CN¥16.19 Billion ≈ $2.37 Billion	+15.83%
2022-12-31	CN¥13.98 Billion ≈ $2.05 Billion	+22.61%
2021-12-31	CN¥11.40 Billion ≈ $1.67 Billion	+68.66%
2020-12-31	CN¥6.76 Billion ≈ $989.06 Million	+55.73%
2019-12-31	CN¥4.34 Billion ≈ $635.11 Million	+25.79%
2018-12-31	CN¥3.45 Billion ≈ $504.89 Million	+14.25%
2017-12-31	CN¥3.02 Billion ≈ $441.93 Million	+34.94%
2016-12-31	CN¥2.24 Billion ≈ $327.50 Million	+36.70%
2015-12-31	CN¥1.64 Billion ≈ $239.58 Million	-8.55%
2014-12-31	CN¥1.79 Billion ≈ $261.98 Million	+64.11%
2013-12-31	CN¥1.09 Billion ≈ $159.64 Million	+77.27%
2012-12-31	CN¥615.39 Million ≈ $90.05 Million	--

About Dashenlin Pharm Grp Co Ltd

SHG:603233 China Pharmaceutical Retailers

Market Cap

$2.96 Billion

CN¥20.21 Billion CNY

Market Cap Rank

#5008 Global

#868 in China

Share Price

CN¥17.75

Change (1 day)

-1.11%

52-Week Range

CN¥14.80 - CN¥21.27

All Time High

CN¥57.53